295 related articles for article (PubMed ID: 16258457)
1. Participation in cancer trials: recruitment of underserved populations.
Paskett ED; Katz ML; DeGraffinreid CR; Tatum CM
Clin Adv Hematol Oncol; 2003 Oct; 1(10):607-13. PubMed ID: 16258457
[TBL] [Abstract][Full Text] [Related]
2. Reducing cancer disparities for minorities: a multidisciplinary research agenda to improve patient access to health systems, clinical trials, and effective cancer therapy.
Bruner DW; Jones M; Buchanan D; Russo J
J Clin Oncol; 2006 May; 24(14):2209-15. PubMed ID: 16682741
[TBL] [Abstract][Full Text] [Related]
3. Recruiting minorities where they receive care: Institutional barriers to cancer clinical trials recruitment in a safety-net hospital.
Joseph G; Dohan D
Contemp Clin Trials; 2009 Nov; 30(6):552-9. PubMed ID: 19580887
[TBL] [Abstract][Full Text] [Related]
4. Closing the divide: diverse populations and cancer survivorship.
Guidry JJ; Torrence W; Herbelin S
Cancer; 2005 Dec; 104(11 Suppl):2577-83. PubMed ID: 16258930
[TBL] [Abstract][Full Text] [Related]
5. Factors that affect breast cancer treatment: underserved and minority populations.
Hurd TC; James T; Foster JM
Surg Oncol Clin N Am; 2005 Jan; 14(1):119-30, vii. PubMed ID: 15542003
[TBL] [Abstract][Full Text] [Related]
6. Barriers and facilitators to participation of minorities in clinical trials.
Schmotzer GL
Ethn Dis; 2012; 22(2):226-30. PubMed ID: 22764647
[TBL] [Abstract][Full Text] [Related]
7. Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience.
McCaskill-Stevens W; McKinney MM; Whitman CG; Minasian LM
J Clin Oncol; 2005 Aug; 23(22):5247-54. PubMed ID: 16051967
[TBL] [Abstract][Full Text] [Related]
8. Lay patient navigator program implementation for equal access to cancer care and clinical trials: essential steps and initial challenges.
Steinberg ML; Fremont A; Khan DC; Huang D; Knapp H; Karaman D; Forge N; Andre K; Chaiken LM; Streeter OE
Cancer; 2006 Dec; 107(11):2669-77. PubMed ID: 17078056
[TBL] [Abstract][Full Text] [Related]
9. Applying community-based participatory research principles and approaches in clinical trials: forging a new model for cancer clinical research.
Seifer SD; Michaels M; Collins S
Prog Community Health Partnersh; 2010; 4(1):37-46. PubMed ID: 20364077
[TBL] [Abstract][Full Text] [Related]
10. Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.
Newman LA; Lee CT; Parekh LP; Stewart AK; Thomas CR; Beltran RA; Lucci A; Green B; Ota D; Nelson H;
Cancer; 2006 Jan; 106(1):188-95. PubMed ID: 16333856
[TBL] [Abstract][Full Text] [Related]
11. Applying justice in clinical trials for diverse populations.
Tilburt J; Ford JG; Howerton MW; Gary TL; Lai GY; Bolen S; Baffi C; Wilson RF; Tanpitukpongse TP; Powe NR; Bass EB; Sugarman J
Clin Trials; 2007; 4(3):264-9. PubMed ID: 17715253
[TBL] [Abstract][Full Text] [Related]
12. Putting patients on trial.
Ortolon K
Tex Med; 2003 Apr; 99(4):37-9. PubMed ID: 12723420
[No Abstract] [Full Text] [Related]
13. Clinical trial accrual among new cancer patients at a community-based cancer center.
Go RS; Frisby KA; Lee JA; Mathiason MA; Meyer CM; Ostern JL; Walther SM; Schroeder JE; Meyer LA; Umberger KE
Cancer; 2006 Jan; 106(2):426-33. PubMed ID: 16353206
[TBL] [Abstract][Full Text] [Related]
14. Increasing accrual in cancer clinical trials with a focus on minority enrollment: The William Beaumont Hospital Community Clinical Oncology Program Experience.
Vicini F; Nancarrow-Tull J; Shah C; Chmielewski G; Fakhouri M; Sitarek SA; Feczko CT; Brzozowski C; Felten DL
Cancer; 2011 Oct; 117(20):4764-71. PubMed ID: 21455995
[TBL] [Abstract][Full Text] [Related]
15. Disparities in participation in cancer clinical trials in the United States : a symptom of a healthcare system in crisis.
Colon-Otero G; Smallridge RC; Solberg LA; Keith TD; Woodward TA; Willis FB; Dunn AN
Cancer; 2008 Feb; 112(3):447-54. PubMed ID: 18085590
[TBL] [Abstract][Full Text] [Related]
16. Why ethnic minority groups are under-represented in clinical trials: a review of the literature.
Hussain-Gambles M; Atkin K; Leese B
Health Soc Care Community; 2004 Sep; 12(5):382-8. PubMed ID: 15373816
[TBL] [Abstract][Full Text] [Related]
17. Knowledge, attitudes, and practices of underserved women in the rural South toward breast cancer prevention and detection.
Avis-Williams A; Khoury A; Lisovicz N; Graham-Kresge S
Fam Community Health; 2009; 32(3):238-46. PubMed ID: 19525705
[TBL] [Abstract][Full Text] [Related]
18. What motivates minorities to participate in research?
Khaliq W; Gross M; Thyagarajan B; Jones-Webb R
Minn Med; 2003 Oct; 86(10):39-42. PubMed ID: 14621943
[TBL] [Abstract][Full Text] [Related]
19. Cancer prevention trials and primary care physicians: factors associated with recommending trial enrollment.
Battaglia TA; Ash A; Prout MN; Freund KM
Cancer Detect Prev; 2006; 30(1):34-7. PubMed ID: 16476525
[TBL] [Abstract][Full Text] [Related]
20. Recruiting participants to cancer prevention clinical trials: lessons from successful community oncology networks.
McKinney MM; Weiner BJ; Wang V
Oncol Nurs Forum; 2006 Sep; 33(5):951-9. PubMed ID: 16955123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
